ORCHID PHARMA LTD.

NSE : ORCHPHARMABSE : 524372ISIN CODE : INE191A01027Industry : Pharmaceuticals & DrugsHouse : Private
BSE1045.20-4.25 (-0.4 %)
PREV CLOSE ( ) 1049.45
OPEN PRICE ( ) 1065.45
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3124
TODAY'S LOW / HIGH ( )1031.00 1069.45
52 WK LOW / HIGH ( )371.2 1358.8
NSE1044.85-6.85 (-0.65 %)
PREV CLOSE( ) 1051.70
OPEN PRICE ( ) 1051.70
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1044.85 (690)
VOLUME 40583
TODAY'S LOW / HIGH( ) 1007.05 1068.00
52 WK LOW / HIGH ( )372.65 1359.95
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Profit Before Tax463.18-19.51-1165.30-1310.70694.08
Adjustment513.80367.661721.531395.67573.35
Changes In working Capital-790.62595.66-369.60618.85-1104.43
Cash Flow after changes in Working Capital186.37943.81186.63703.82163.00
Cash Flow from Operating Activities183.38924.75235.86808.03120.24
Cash Flow from Investing Activities-312.141129.36672.051671.12454.73
Cash Flow from Financing Activities311.66-2167.98-1649.89-2503.35-3.00
Net Cash Inflow / Outflow182.91-113.87-741.98-24.19571.98
Opening Cash & Cash Equivalents43.07156.94898.92923.11351.13
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent225.9743.07156.94898.92923.11

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.